Subarachnoid Hemorrhage-Related Epilepsy

  • Warren BolingEmail author
  • Lydia Kore
Part of the Acta Neurochirurgica Supplement book series (NEUROCHIRURGICA, volume 127)


Epilepsy is a significant worldwide public health problem that leads to reduced quality of life and negative psychosocial consequences and significantly increases mortality rates in those who are affected. The development of epilepsy from subarachnoid hemorrhage (SAH) has an important negative impact on long-term survival, functional status, and cognitive recovery in patients following aneurysmal rupture. Anticonvulsant medication (AED) administration to prevent the development of epilepsy following SAH is controversial, and studies to date have not shown effectiveness of AED use as prophylaxis. This paper reviews the pathophysiology of SAH in the development of epilepsy, the scope of the problem of epilepsy related to SAH, and the studies that have evaluated AED administration as prophylaxis for seizures and epilepsy.


Conflict of Interest

The authors affirm that they have no conflicts of interest related to this manuscript.


  1. 1.
    Abdul-Muneer PM, Chandra N, Haorah J. Interactions of oxidative stress and neurovascular inflammation in the pathogenesis of traumatic brain injury. Mol Neurobiol. 2015;51:966–79.CrossRefGoogle Scholar
  2. 2.
    Baker GA. The psychosocial burden of epilepsy. Epilepsia. 2002;43(Suppl 6):26–30.CrossRefGoogle Scholar
  3. 3.
    Barker-Haliski ML, Löscher W, White HS, Galanopoulou AS. Neuroinflammation in epileptogenesis. Epilepsia. 2017;58(Suppl 3):39–47.CrossRefGoogle Scholar
  4. 4.
    Baumann RJ, Marx BM, Leonidakis MG. An estimate of the prevalence of epilepsy in a rural Appalachian population. Am J Epidemiol. 1977;106:42–52.CrossRefGoogle Scholar
  5. 5.
    Birbeck G, Chomba E, Atadzhanov M, Mbewe E, Haworth A. The social and economic impact of epilepsy in Zambia: a cross-sectional study. Lancet Neurol. 2007;6:39–44.CrossRefGoogle Scholar
  6. 6.
    De Marchis GM, Pugin D, Meyers E, Velasquez A, Suwatcharangkoon S, Park S, Falo MC, Agarwal S, Mayer S, Schmidt JM, Connolly ES, Claassen J. Seizure burden in subarachnoid hemorrhage associated with functional and cognitive outcome. Neurology. 2016;86:253–60.CrossRefGoogle Scholar
  7. 7.
    Fletcher A, Sims-Williams H, Wabulya A, Boling W. Stigma and quality of life at long-term follow-up after surgery for epilepsy in Uganda. Epilepsy Behav. 2015;52:128–31.CrossRefGoogle Scholar
  8. 8.
    Helmstaedter C, Elger CE. Chronic temporal lobe epilepsy: a neurodevelopmental or progressively dementing disease? Brain. 2009;132:2822–30.CrossRefGoogle Scholar
  9. 9.
    Hesdorffer DC, Beck V, Begley CE, Bishop ML, Cushner-Weinstein S, Holmes GL, Shafer PO, Sirven JI, Austin JK. Research implications of the Institute of Medicine Report, Epilepsy Across the Spectrum: Promoting Health and Understanding. Epilepsia. 2013;54:207–16.CrossRefGoogle Scholar
  10. 10.
    Human T, Diringer MN, Allen M, Zipfel GJ, Chicoine M, Dacey R, Dhar R. A randomized trial of brief versus extended seizure prophylaxis after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2018;28(2):169–74. Scholar
  11. 11.
    Huttunen J, Kurki MI, von Und Zu Fraunberg M, Koivisto T, Ronkainen A, Rinne J, Jääskeläinen JE, Kälviäinen R, Immonen A. Epilepsy after aneurysmal subarachnoid hemorrhage: a population-based, long-term follow-up study. Neurology. 2015;84:2229–37.CrossRefGoogle Scholar
  12. 12.
    Huttunen J, Lindgren A, Kurki MI, Huttunen T, Frösen J, Koivisto T, von Und Zu Fraunberg M, Immonen A, Jääskeläinen JE, Kälviäinen R. Epilepsy-associated long-term mortality after aneurysmal subarachnoid hemorrhage. Neurology. 2017;89:263–8.CrossRefGoogle Scholar
  13. 13.
    Kaddumukasa M, Mugeny L, Kaddumukasa MN, Ddumba E, Devereaux M, Furlan A, Sajatovic M, Katabira E. Prevalence and incidence of neurological disorders among adult Ugandans in rural and urban Mukono district; a cross-sectional study. BMC Neurol. 2016;16:227.CrossRefGoogle Scholar
  14. 14.
    Korff CM, Dale RC. The immune system in pediatric seizures and epilepsies. Pediatrics. 2017. Scholar
  15. 15.
    Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. 2000;342:314–9.CrossRefGoogle Scholar
  16. 16.
    Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, Moshé SL, Perucca E, Wiebe S, French J. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51:1069–77.CrossRefGoogle Scholar
  17. 17.
    Marigold R, Günther A, Tiwari D, Kwan J. Antiepileptic drugs for the primary and secondary prevention of seizures after subarachnoid haemorrhage. 2013. Accessed 1 Mar 2018.
  18. 18.
    Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study. Lancet. 2012;380:2197–223.CrossRefGoogle Scholar
  19. 19.
    Naidech AM, Kreiter KT, Janjua N, Ostapkovich N, Parra A, Commichau C, Connolly ES, Mayer SA, Fitzsimmons BF. Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke. 2005;36:583–7.CrossRefGoogle Scholar
  20. 20.
    Olafsson E, Gudmundsson G, Hauser WA. Risk of epilepsy in long-term survivors of surgery for aneurysmal subarachnoid hemorrhage: a population-based study in Iceland. Epilepsia. 2000;41:1201–5.CrossRefGoogle Scholar
  21. 21.
    Panczykowski D, Pease M, Zhao Y, Weiner G, Ares W, Crago E, Jankowitz B, Ducruet AF. Prophylactic antiepileptics and seizure incidence following subarachnoid hemorrhage: a propensity score-matched analysis. Stroke. 2016;47:1754–60.CrossRefGoogle Scholar
  22. 22.
    Raper DM, Starke RM, Komotar RJ, Allan R, Connolly ES Jr. Seizures after aneurysmal subarachnoid hemorrhage: a systematic review of outcomes. World Neurosurg. 2013;79:682–90.CrossRefGoogle Scholar
  23. 23.
    Regan RF, Panter SS. Neurotoxicity of hemoglobin in cortical cell culture. Neurosci Lett. 1993;153:219–22.CrossRefGoogle Scholar
  24. 24.
    Rush B, Wiskar K, Fruhstorfer C, Hertz P. Association between seizures and mortality in patients with aneurysmal subarachnoid hemorrhage: a nationwide retrospective cohort analysis. Seizure. 2016;41:66–9.CrossRefGoogle Scholar
  25. 25.
    Sadrzadeh SMH, Eaton JW. Hemoglobin-mediated oxidant damage to the central nervous system requires endogenous ascorbate. J Clin Invest. 1988;82:1510–5.CrossRefGoogle Scholar
  26. 26.
    Sperling MR, Feldman H, Kinman J, Liporace JD, O’Connor MJ. Seizure control and mortality in epilepsy. Ann Neurol. 1999;46:45–50.CrossRefGoogle Scholar
  27. 27.
    Ueda Y, Willmore LJ, Triggs WJ. Amygdalar injection of FeCl3 causes spontaneous recurrent seizures. Exp Neurol. 1998;153:123–7.CrossRefGoogle Scholar
  28. 28.
    van Vliet EA, Aronica E, Vezzani A, Ravizza T. Review: neuroinflammatory pathways as treatment targets and biomarker candidates in epilepsy: emerging evidence from preclinical and clinical studies. Neuropathol Appl Neurobiol. 2018;44:91–111.CrossRefGoogle Scholar
  29. 29.
    Vezzani A, French J, Bartfai T, Baram TZ. The role of inflammation in epilepsy. Nat Rev Neurol. 2011;7:31–40.CrossRefGoogle Scholar
  30. 30.
    Willmore LJ, Sypert GW, Munson JB, Hurd RW. Chronic focal epileptiform discharges induced by injection of iron into rat and cat cortex. Science. 1978;200:1501–3.CrossRefGoogle Scholar
  31. 31.
    Yip S, Sastry B. Effects of hemoglobin and its breakdown products on synaptic transmission in rat hippocampal CA1 neurons. Brain Res. 2000;864:1–12.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of NeurosurgeryLoma Linda UniversityLoma LindaUSA
  2. 2.Loma Linda University, School of MedicineLoma LindaUSA

Personalised recommendations